Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPREOMYCIN Cause Electrocardiogram qt prolonged? 74 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Electrocardiogram qt prolonged have been filed in association with CAPREOMYCIN. This represents 18.6% of all adverse event reports for CAPREOMYCIN.

74
Reports of Electrocardiogram qt prolonged with CAPREOMYCIN
18.6%
of all CAPREOMYCIN reports
15
Deaths
28
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From CAPREOMYCIN?

Of the 74 reports, 15 (20.3%) resulted in death, 28 (37.8%) required hospitalization, and 19 (25.7%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPREOMYCIN. However, 74 reports have been filed with the FAERS database.

What Other Side Effects Does CAPREOMYCIN Cause?

Off label use (53) Drug resistance (49) Vomiting (34) Anaemia (29) Neuropathy peripheral (28) Hepatotoxicity (27) Intentional product use issue (24) Nausea (24) Dyspnoea (22) Product use in unapproved indication (22)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which CAPREOMYCIN Alternatives Have Lower Electrocardiogram qt prolonged Risk?

CAPREOMYCIN vs CAPSAICIN CAPREOMYCIN vs CAPTOPRIL CAPREOMYCIN vs CARBAMAZEPINE CAPREOMYCIN vs CARBETOCIN CAPREOMYCIN vs CARBIDOPA

Related Pages

CAPREOMYCIN Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged CAPREOMYCIN Demographics